Cleared Traditional

K203026 - AltiVate Anatomic Pegged Glenoid with M...

K203026 is the FDA 510(k) clearance for AltiVate Anatomic Pegged Glenoid with M... by Encore Medical, L.P.. It is a Class 2 Orthopedic device (product code KWS) cleared through the Traditional 510(k) pathway after a 82-day FDA review.

K203026 · Encore Medical, L.P. · Orthopedic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2020
Decision
82d
Days
Class 2
Risk

K203026 is an FDA 510(k) clearance for the AltiVate® Anatomic Pegged Glenoid with Markers. Classified as Prosthesis, Shoulder, Semi-constrained, Metal/polymer Cemented (product code KWS), Class II - Special Controls.

Submitted by Encore Medical, L.P. (Austin, US). The FDA issued a Cleared decision on December 23, 2020 after a review of 82 days - a notably fast clearance cycle.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3660 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Encore Medical, L.P. devices

Submission Details

510(k) Number K203026 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 02, 2020
Decision Date December 23, 2020
Days to Decision 82 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
40d faster than avg
Panel avg: 122d · This submission: 82d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code KWS Prosthesis, Shoulder, Semi-constrained, Metal/polymer Cemented
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3660
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Peers - KWS Prosthesis, Shoulder, Semi-constrained, Metal/polymer Cemented

All 152
Devices cleared under the same product code (KWS) and FDA review panel - the closest regulatory comparables to K203026.
Augmented VaultLock Glenoid
K210050 · Arthrex, Inc. · Jun 2021
BLUEPRINT™ Patient Specific Instrumentation
K203315 · Tornier S.A.S. · Apr 2021
Global Shoulder and Delta CTA systems
K203230 · Depuy Lnc. · Apr 2021
ReUnion Reversible Fracture System (RFX), ReUnion Reverse Shoulder Arthroplasty System (RSA), ReUnion Total Shoulder Arthroplasty System (TSA)
K202289 · Stryker GmbH · Dec 2020
Alliance Augmented Glenoid
K193180 · Zimmer, Inc. · Feb 2020
SmartSPACE Shoulder System
K191247 · Techmah Medical, LLC · Nov 2019